| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.38 | 0.02 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |